IP strategy

A focused, commercially aligned approach for innovators

Align IP with scientific, clinical, regulatory, and commercial milestones, ensuring protection evolves in lockstep with asset development and market pathways

  • Build investor‑ready IP portfolios that clearly articulate differentiation, defendability, and value, strengthening credibility and funding potential for biotech and pharma innovators

  • Provide cross‑functional IP strategy integrating R&D priorities, clinical strategy, regulatory considerations, legal risk, and commercial goals to create a unified, forward‑looking IP plan

  • Identify risks early through proactive assessment of freedom‑to‑operate, competitive landscapes, and emerging threats, reducing cost, delays, and downstream friction

  • Deliver senior‑level strategic execution, offering boutique, hands‑on support for complex life‑science IP challenges where nuance, timing, and scientific insight are critical

  • In biotech and pharma, IP is the business. It defines exclusivity, underpins valuation, shapes partnership terms, and determines whether investors see a viable path to market. A strong IP strategy protects not just molecules or methods, but the scientific insight, data, and know‑how that create competitive advantage. Without a coherent strategy, even excellent science struggles to translate into fundable, defensible products.

  • A biotech‑relevant IP strategy goes far beyond filing patents. It covers:

    • Identifying protectable scientific and technical assets

    • Mapping inventions to therapeutic, diagnostic, or platform value

    • Choosing between patents, trade secrets, data exclusivity, and regulatory pathways

    • Ensuring clean ownership across academic collaborations, CROs, and consultants

    • Aligning IP with clinical, regulatory, and commercial milestones

    • Preparing a credible IP narrative for investors and partners

    The goal is clarity: what to protect, why it matters, and how it supports your path to market.

  • My approach is structured, pragmatic, and tailored to the realities of life‑science development:

    • Deep‑dive into your science, data, and competitive landscape

    • Identify gaps, risks, and opportunities in your current IP position

    • Build a coherent, investor‑ready IP story

    • Prioritise filings and protection routes based on commercial impact

    • Integrate IP with regulatory strategy, clinical plans, and partnering goals

    • Establish practical processes for invention capture and confidentiality

    Everything is designed to be implementable, not theoretical, and to strengthen your defensibility at every stage.

  • Timing is critical in biotech. Acting too early wastes resources; acting too late risks losing novelty or leverage.

    You need an IP strategy when you are:

    • Preparing for pre‑seed, seed, or Series A fundraising

    • Moving from discovery into preclinical development

    • Entering collaborations with universities, CROs, or industry partners

    • Generating data that could form the basis of a patent

    • Planning regulatory submissions or clinical entry

    • Preparing for due diligence or a transaction

    The right sequencing protects your science, supports valuation, and positions you strongly for partnerships and investment.

Work with us
IP strategy aligned with your business strategy. IP aligned with clinical data with regulatory pathways. Value-driven IP strategy. A black and white photo of a hand about to move a white king chess piece on a chessboard.

Founder enablement insights

  • We provide below a curated overview of the most relevant instruments supporting patents, trademarks, designs, and early-stage IP strategy, complete with application timelines and official links for direct execution by founders and SMEs.

    Denmark

    DKPTO SME voucher (Patentvoucher and Startpakker)

    Supports patent drafting, prior-art searches, IP strategy development, and official filings.

    • Coverage: Up to 75% of costs, maximum DKK 75,000 per year.

    • Timeline: Rolling applications; funds available until the annual budget is exhausted.

    • Official Link: https://www.dkpto.dk

    EUopSTART (Horizon Europe & EDF)

    Funding for Danish SMEs preparing proposals for the EU Defence Fund or Horizon Europe. IP-related costs incurred during proposal preparation are eligible.

    • 2026 Deadlines:

      • February 27, 2026, 12:00 CET

      • May 29, 2026, 12:00 CET

      • August 28, 2026, 12:00 CET

      • November 4, 2026, 12:00 CET

    • Official Link: https://ufm.dk (via e-grant portal)

    European Union

    EUIPO SME Fund 2026

    Reimbursement for costs associated with patents, trademarks, designs, plant varieties, and IP scans.

    • Application window: February 2, 2026 → December 4, 2026

    • Activation: Vouchers must be activated within 1 month (extendable to 2 months).

    • Note: First-come, first-served basis; early application is strongly recommended.

    • Official Link: https://euipo.europa.eu

    Eurostars (Eureka Network)

    Supports international R&D collaborations. Patenting and IP protection costs can be integrated into project budgets.

    Nordics

    Explore specific support instruments available in Sweden, Norway, and Finland.

    Sweden: PRV SME Support

    Swedish SMEs can access funding for IP scans, patentability assessments, and early-stage IP strategy development.

    Norway: Patentstyret SME Support

    While Norway does not offer a dedicated SME voucher scheme identical to the EUIPO, Norwegian SMEs can leverage:

    • National support instruments (e.g., Innovation Norway programmes).

    • Patentstyret provides comprehensive IP services and guidance; funding options vary by programme.

    • Official Link: https://www.patentstyret.no

    Finland: Business Finland Innovation Voucher

    Can be utilized for IP consulting, various protection activities, and early strategic IP assessments.

    • Voucher Value: €6,000 (100% funding of expert services, excluding VAT).

    • Timeline: Rolling calls; subject to annual budget availability.

    • Official Link: https://www.businessfinland.fi

    Navigate your IP protection journey with confidence. Need expert guidance in securing these funding opportunities or developing a robust IP strategy tailored to your innovation?

    Contact Elevate IP Advisory for a personalized consultation today. Email us at ek@elevateipadvisory.com.